These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11738337)

  • 1. The chemotherapeutic agent bleomycin in a two-drug combination with zidovudine, ritonavir or indinavir synergistically inhibits HIV Type-1 replication in peripheral blood lymphocytes.
    Georgiou NA; van der Bruggen T; Jansen CA; Oudshoorn M; Nottet HS; Marx JJ; van Asbeck BS
    Int J Antimicrob Agents; 2001 Dec; 18(6):513-8. PubMed ID: 11738337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleomycin has antiviral properties against drug-resistant HIV strains and sensitises virus to currently used antiviral agents.
    Georgiou NA; van der Bruggen T; Healy DM; van Tienen C; de Bie P; Oudshoorn M; Marx JJ; van Asbeck BS
    Int J Antimicrob Agents; 2006 Jan; 27(1):63-8. PubMed ID: 16332431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The triple combination indinavir-zidovudine-lamivudine is highly synergistic.
    Snyder S; D'Argenio DZ; Weislow O; Bilello JA; Drusano GL
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1051-8. PubMed ID: 10722511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
    Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.
    Savarino A; Lucia MB; Rastrelli E; Rutella S; Golotta C; Morra E; Tamburrini E; Perno CF; Boelaert JR; Sperber K; Cauda R
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):223-32. PubMed ID: 15076236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of phosphazide and crixivan inhibit replication of HIV-1 strains that are resistant to azidothymidine].
    Selimova LM; Kraevskiĭ AA; Galegov GA
    Dokl Akad Nauk; 1999 Dec; 369(6):847-9. PubMed ID: 10687056
    [No Abstract]   [Full Text] [Related]  

  • 7. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.
    Su J; Andersson E; Horal P; Naghavi MH; Palm A; Wu YP; Eriksson K; Jansson M; Wigzell H; Svennerholm B; Vahlne A
    J Hum Virol; 2001; 4(1):1-7. PubMed ID: 11213928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin.
    Georgiou NA; van der Bruggen T; Oudshoorn M; Nottet HS; Marx JJ; van Asbeck BS
    J Infect Dis; 2000 Feb; 181(2):484-90. PubMed ID: 10669330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
    Koup RA; Brewster F; Grob P; Sullivan JL
    AIDS; 1993 Sep; 7(9):1181-4. PubMed ID: 7692883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro.
    Merrill DP; Manion DJ; Chou TC; Hirsch MS
    J Infect Dis; 1997 Jul; 176(1):265-8. PubMed ID: 9207379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrations.
    Marschner IC; Mayers DL; Erice A; Smeaton L; Johnson VA; Richman DD; Reichelderfer P; Japour AJ
    J Clin Microbiol; 1997 Mar; 35(3):756-8. PubMed ID: 9041428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine.
    Viani RM; Gutteberg TJ; Lathey JL; Spector SA
    AIDS; 1999 Jul; 13(10):1273-4. PubMed ID: 10416533
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-1 protease inhibitors. A review for clinicians.
    Deeks SG; Smith M; Holodniy M; Kahn JO
    JAMA; 1997 Jan; 277(2):145-53. PubMed ID: 8990341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-drug combination of MKC-442, lamivudine and zidovudine in vitro: potential approach towards effective chemotherapy against HIV-1.
    Piras G; Nakade K; Yuasa S; Baba M
    AIDS; 1997 Mar; 11(4):469-75. PubMed ID: 9084794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.
    Eron JJ; Johnson VA; Merrill DP; Chou TC; Hirsch MS
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1559-62. PubMed ID: 1324648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.
    Vermeire K; Princen K; Hatse S; De Clercq E; Dey K; Bell TW; Schols D
    AIDS; 2004 Nov; 18(16):2115-25. PubMed ID: 15577644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of the human immunodeficiency virus type 1 by the oxygen radical generating agent bleomycin.
    Georgiou NA; van der Bruggen T; Oudshoorn M; de Bie P; Jansen CA; Nottet HS; Marx JJ; van Asbeck BS
    Antiviral Res; 2004 Aug; 63(2):97-106. PubMed ID: 15302138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
    Johnson VA; Barlow MA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine.
    Johnson VA; Walker BD; Barlow MA; Paradis TJ; Chou TC; Hirsch MS
    Antimicrob Agents Chemother; 1989 Jan; 33(1):53-7. PubMed ID: 2653214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.